SCHEMBL9255368

SCHEMBL9255368

O[CH]C/C=C/c1ccsc1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.51
TAS1R3 Q7RTX0 2/20 0.40
TAS1R1 Q7RTX1 2/20 0.40
GUSB P08236 1/20 0.38
PPARA Q07869 2/20 0.35
PPARG P37231 1/20 0.35
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
JAK2 O60674 1/20 0.33
EGFR P00533 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
ALDH1A1 P00352 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9255367 0.81
SCHEMBL9255381 0.81
SCHEMBL9251531 0.78 ALOX5 (0.50) ALOX5TAS1R3TAS1R1GUSBPPARA
SCHEMBL9251543 0.78 ALOX5 (0.50) ALOX5TAS1R3TAS1R1GUSBPPARA
SCHEMBL7291751 0.77
SCHEMBL9385262 0.77
SCHEMBL9253492 0.77
SCHEMBL14416286 0.77
SCHEMBL9871221 0.77
SCHEMBL13984590 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5439932-A Anticholesterol agents BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-08 US disclosed
US-5306728-A Substituted amine derivatives having antihyperlipemia activity BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-04-26 US disclosed
EP-0448078-A2 Substituted amine derivatives having anti-hyperlipemia activity BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-09-25 EP disclosed